Blood-testing company Theranos had no revenue in 2015, 2016
Blood testing technology startup Theranos did not make any material revenue in both 2015 and 2016, according to reports. The company is reportedly running out of cash as it had $200 million left at the end of 2016, a quarter of its $800 million in total funding. Notably, the startup was valued at $9 billion in 2014.